General Chat, page-951

Thanks for that history lesson. Might do more digging later on. Whilst the tech has taken some time to develop, I don't think we should be judging MEMs future based on the history, especially as the current management team and board of directors is stretch away from the initial team. Unless the KOLs come back with negative feedback, which based on recent announcements it does not seem likely, it seems MEM is on track to commercialization. I do agree that biotech, or any other new tech that challenges the status quo, will have difficulties penetrating the market, however the global change management strategies that's been adopted shows promise. With growing vested interest in several other well established organisations (e.g., Monash IVF) I think we can hold a degree of confidence that we can judge the company as it stands today rather than on its tattered history.